Home disease objectives contact intranet committees patients

Transeuro Committees

Ethical Committee

consists of healthcare professionals and non-medical members whose responsibility it is to protect the rights, safety and well being of human subjects as well laboratory animals involved in the study. The committee performs overall ethical reviews of the projects that involve collaborations between partners in different sites, particularly if exchange of patient data or material is involved.


Trial Safety Monitoring Committee

consists of independent clinical trial experts to provide overall supervision of the trial and ensure that it is being conducted in accordance with the principles of GCP and the relevant regulations. Additionally, the committee should provide advice to the investigators on all aspects of the trial.


Scientific Advisory Board

consists of external specialists with a role to analyse the annual reports and progress of the project through presentations given by consortium members and to offer independent, impartial advice on potential areas for improvement and new avenues to explore.


Ethical Committee


Herbert Gottweis

University of Vienna, Austria

† 31 March 2014

Professor Herbert Gottweis died in Vienna on March 31st, 2014. With his death, Transeuro's members have lost invaluable insights and advices on how to handle the impact of clinical studies on the society and politics. Herbert Gottweis was professor at the Department of Political Science, University of Vienna. He founded and directed the Life Science Governance Institute in Vienna, an interdisciplinary research institute that studies the interface between life sciences and governance. Gottweis had a strong theoretical and methodological interest in policy research and linked in his work on theoretical oriented questions with his interest in addressing concrete problems of contemporary policy making and governance.
He was the coordinator of the projects funded under the 6th EU Framework program (PAGANINI) and he was also a partner on other EU projects, including REMEDiE (Regenerative medicine) and BBMRI (Biobanking and biomolecular research resources infrastructure).



Ruth Chadwick

Cardiff University, UK

Professor Ruth Chadwick is Distinguished Research Professor at Cardiff University and Director of CESAGen. She is based in Cardiff Law School. She held positions in Liverpool, Cardiff, Preston and Lancaster before joining the University in 2006. She co-ordinated the Euroscreen projects (1994-6; 1996-9) funded by the European Commission and co-edits the journal Bioethics



Alasdair Coles

Cambridge University, UK

Professor Alasdair Coles is Lecturer in Neuro Immunology at the University of Cambridge. His research interests include investigation novel treatments of multiple sclerosis (MS), especially alemtuzumab (Campath-1H), a humanized monoclonal antibody used in therapy against such disorders as leukemia, lymphomas, multiple sclerosis.
Additionally, he is studying immunology and immunotherapy of patients with cerebral lupus and vasculitis.
He is an ordained Minister in the Anglican Church



Jasper Bovenberg

University of Amsterdam, The Nederlands

Jasper Bovenberg handles a wide variety of contentious and non-contentious issues relating to the healthcare sector, including healthcare insurance and the provision of primary and secondary care by independent healthcare centres. Specifically, he counsels on all legal aspects associated with medical innovations and regenerative medicine in the area of tissue-engineering and biobanking. Being a member of a number of national and international oversight bodies secures him readily access to and firsthand experience with the rapid and cutting edge developments in this area.



Charles Holme

Special Parkinson's Research Interest Group, UK

Charles Holme chairs the Special Parkinson's Research Interest Group (SPRING) Committee in the UK. SPRING is comprised of members of Parkinson's UK (Parkinson’s patients Association) who are interested in research and are fervent about helping to bring closer a cure to Parkinson's and related conditions. Through its members SPRING is involved in a number of activities and is always looking for other opportunities to promote research towards the improvement of the lives of people affected by Parkinson's Disease.


Go to top

Trial Monitoring Committee


Werner Poewe

Medical University of Insbruck, Austria

Professor Werner Poewe is Professor of Neurology and Director of the Department of Neurology at Innsbruck Medical University as well as President of the Austrian Parkinson’s disease Society. Professor Poewe’s research interests are in the field of movement disorders with particular emphasis on the pharmacology of Parkinson’s disease and dystonia.



Marc Levivier

Univerity Hospital Lausanne, Switzerland

Professor Marc Levivier is leading Neurosurgery Department at the University Hospital Lausanne. His neurosurgery specialization is the treatment of brain tumors by stereotaxic and functional surgery (abnormal movements, epilepsy, and pain). He is collaborating with the EPF in Brussels in the development of new, computer-assisted techniques guided by imaging (PET-scanning), therapies to remove brain tumors. He has been involved in the development of the first European protocols for neuronal transplantations in Parkinson’s patients, and more lately for Huntington’s disease patients. Marc Levivier is an international expert in radiosurgery using the non-invasive technique of Gamma Knife.



Prof. Gilles Defer

Caen University Hospital, France

Prof. Gilles Defer is leading the Neurology Department at the University Hospital of Caen (France). His clinical department is treating several types of neurologic disorders, including stroke. He is a leading French neurologist in the domain of multiple sclerosis, Parkinson’s and Alzheimer’s diseases, and the treatment of cognitive deficits associated with these disorders.



Prof. Eduardo Tolosa

University of Barcelona, Spain

Prof. Eduardo Tolosa is Chief of Neurology and Director of the Parkinson’s Disease and Movement Disorder Unit at the University Hospital in Barcelona. Professor Tolosa research interest have centered on movement disorders and particularly in issues related to experimental therapeutics, etiology and pathophysiology of various Parkinson syndromes.


Go to top

Scientific Advisory Board


Yoav Ben-Shlomo

University of Bristol, UK

Professor Yoav Ben-Shlomo is an internationally recognized neuro-epidemiologist with wide-spread experience in both population and clinical cohort studies. He has been involved with clinical-pathological diagnostic studies of movement disorders and is part of an MRC diagnostic methodology grant and NINDS working group to develop common data elements for PD.



Andrew Lees

University College London, UK

Professor Andrew Lees is Director of the Reta Lila Weston Institute of Neurological Studies at University College London. He has achieved international recognition for his work in Parkinson’s disease and abnormal movement disorders. In his research, he focuses mainly on clinical-pathological correlations of Parkinson’s disease and Progressive Supranuclear Palsy (PSP) and experimental therapeutics of Parkinson’s disease and PSP.



Clive Svendsen

University of Wisconsin, USA

Professor Clive Svendsen is a pioneer in stem cells research and interested mainly in understanding the molecular mechanisms responsible for their proliferation and differentiation and their safety and efficacy following transplantation.



Jeffrey Kordower

Rush University, USA

Professor Jeffrey Kordower is a leading expert on primate models of neurodegenerative diseases such as Alzheimer‘s disease, Parkinson‘s disease and Huntington‘s disease. He is currently developing gene therapy for Alzheimer‘s disease and Parkinson‘s disease in primate models. Additional research interests include gene therapy, neural transplantation, and morphological and molecular changes in neurodegenerative disease.



Elena Cattaneo

University of Milan, Italy

Professor Elena Cattaneo is Director of the Center for Stem Cell Research of the University of Milan. Her research is focussed on the biology of neural stem cells and their potential application, and on the study of the mechanisms underlying Huntington's disease. Prof Cattaneo's studies on neural stem cells and Huntington's disease saw her awarded the “Le Scienze” Price for Medicine and a Gold Medal from the President of the Italian Republic in 2001. In 2005 she was awarded the Marisa Bellisario and Chiara D’Onofrio prizes, and in 2006 was nominated Cavaliere Ufficiale (Knight) of the Italian Republic.


  Go to top

© Copyright 2010 TRANSEURO